Immediate Impact
61 standout
Citing Papers
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of K. Gattringer being referenced
Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract
2012
Gemella morbillorum Bacteremia after Anti-Tumor Necrosis Factor Alpha as Acne Inversa Therapy
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| K. Gattringer | 84 | 25 | 24 | 140 | 111 | 11 | 307 | |
| M Elliott | 45 | 3 | 81 | 49 | 18 | 8 | 298 | |
| Shadi Ahmadmehrabi | 22 | 15 | 51 | 16 | 16 | 10 | 345 | |
| Conor J. Bloxham | 13 | 118 | 15 | 23 | 36 | 12 | 258 | |
| Craig H. Steffee | 47 | 20 | 62 | 16 | 8 | 16 | 309 | |
| H. Zahra | 21 | 132 | 2 | 61 | 28 | 10 | 264 | |
| Jessica Stevenson | 24 | 5 | 12 | 8 | 19 | 12 | 347 | |
| N’dri Juliette Kadiane-Oussou | 22 | 166 | 2 | 58 | 21 | 8 | 274 | |
| Orsolya Huszár | 20 | 2 | 157 | 32 | 17 | 10 | 365 | |
| Seil Sagar | 27 | 16 | 37 | 6 | 24 | 7 | 351 | |
| Pamir Çerçi | 12 | 31 | 35 | 9 | 9 | 18 | 356 |
All Works
Loading papers...